[1] |
McBride AA. Human papillomaviruses: diversity, infection and host interactions[J]. Nat Rev Microbiol, 2022,20(2):95⁃108. doi: 10.1038/s41579⁃021⁃00617⁃5.
|
[2] |
de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type[J]. Int J Cancer, 2017,141(4):664⁃670. doi: 10.1002/ijc.30716.
|
[3] |
Nuovo G, Schwartz Z, Magro C. A comparison of the detection of biomarkers in infections due to low risk versus high⁃risk human papillomavirus types[J]. Ann Diagn Pathol, 2019,41:57⁃61. doi: 10.1016/j.anndiagpath.2019.05.010.
|
[4] |
Ljubojevic S, Skerlev M. HPV⁃associated diseases[J]. Clin Dermatol, 2014,32(2):227⁃234. doi: 10.1016/j.clindermatol.2013. 08.007.
|
[5] |
Ghorzang E, de Koning M, Bouwes Bavinck JN, et al. HPV type⁃specific distribution among family members and linen in households of cutaneous wart patients[J]. J Eur Acad Dermatol Venereol, 2022,36(1):119⁃125. doi: 10.1111/jdv.17684.
|
[6] |
Cartin W, Alonso A. The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction[J]. Virology, 2003,314(2):572⁃579. doi: 10.1016/s0042⁃6822(03)00509⁃9.
|
[7] |
McBride AA. The papillomavirus E2 proteins[J]. Virology, 2013,445(1⁃2):57⁃79. doi: 10.1016/j.virol.2013.06.006.
|
[8] |
Katoh M, Nakagama H. FGF receptors: cancer biology and therapeutics[J]. Med Res Rev, 2014,34(2):280⁃300. doi: 10. 1002/med.21288.
|
[9] |
Babina IS, Turner NC. Advances and challenges in targeting FGFR signalling in cancer[J]. Nat Rev Cancer, 2017,17(5):318⁃332. doi: 10.1038/nrc.2017.8.
|
[10] |
Xie F, DeSmet M, Kanginakudru S, et al. Kinase activity of fibroblast growth factor receptor 3 regulates activity of the papillomavirus E2 protein[J]. J Virol, 2017,91(20):e01066⁃e01017. doi: 10.1128/JVI.01066⁃17.
|
[11] |
Xie F, Bai J, Meng XF, et al. Role of FGFR3 in proliferation and differentiation of high⁃risk HPV⁃positive cells[J]. Int J Dermatol Venereol, 2022. doi:10.1097/JD9.0000000000000268.
|
[12] |
唐洪波, 马庆宇, 桑莹冰, 等. 紫外线和人乳头状瘤病毒16 E6协同诱导、促进裸鼠皮肤鳞状细胞癌的机制研究[J]. 中华皮肤科杂志, 2022,55(11):982⁃989. doi: 10.35541/cjd.20220084.
|
[13] |
Graham SV. Keratinocyte differentiation⁃dependent human papillomavirus gene regulation[J]. Viruses, 2017,9(9):245. doi: 10.3390/v9090245.
|
[14] |
Ramírez⁃Salazar E, Centeno F, Nieto K, et al. HPV16 E2 could act as down⁃regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation[J]. Virol J, 2011,8:247. doi: 10.1186/1743⁃422X⁃8⁃247.
|
[15] |
Domínguez⁃Catzín V, Reveles⁃Espinoza AM, Sánchez⁃Ramos J, et al. HPV16⁃E2 protein modifies self⁃renewal and differentiation rate in progenitor cells of human immortalized keratinocytes[J]. Virol J, 2017,14(1):65. doi: 10.1186/s12985⁃017⁃0736⁃2.
|
[16] |
Burns JE, Walker HF, Schmitz C, et al. Phenotypic effects of HPV⁃16 E2 protein expression in human keratinocytes[J]. Virology, 2010,401(2):314⁃321. doi: 10.1016/j.virol.2010.03.002.
|
[17] |
Boulabiar M, Boubaker S, Favre M, et al. Keratinocyte sensitization to tumour necrosis factor⁃induced nuclear factor kappa B activation by the E2 regulatory protein of human papillomaviruses[J]. J Gen Virol, 2011,92(Pt 10):2422⁃2427. doi: 10.1099/vir.0.032466⁃0.
|
[18] |
许翠, 何勇, 吴亦琳, 等. 人乳头状瘤病毒16 E6/E7基因稳定表达的永生化角质形成细胞的建立及鉴定[J]. 中华皮肤科杂志, 2022,55(6):501⁃507. doi: 10.35541/cjd.20210874.
|
[19] |
Mandinova A, Kolev V, Neel V, et al. A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans[J]. J Clin Invest, 2009,119(10):3127⁃3137. doi: 10.1172/JCI38543.
|